Exercise During Pregnancy and Urinary Incontinence

Sponsor
Universidad Politecnica de Madrid (Other)
Overall Status
Unknown status
CT.gov ID
NCT03997045
Collaborator
(none)
50
1
2
17
2.9

Study Details

Study Description

Brief Summary

The aim of this study is to examine the effect of a supervised physical exercise program during pregnancy on urinary incontinence.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Supervised physical exercise program
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Care Provider)
Primary Purpose:
Prevention
Official Title:
Effect of Physical Exercise Program During Pregnancy on Urinary Incontinence
Actual Study Start Date :
Mar 1, 2019
Anticipated Primary Completion Date :
Jan 31, 2020
Anticipated Study Completion Date :
Jul 30, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention group

Pregnant women receiving usual care and participating in supervised physical exercise program.

Behavioral: Supervised physical exercise program
Supervised physical conditioning program of two 60-minutes sessions per week during pregnancy, developed from gestational week 20 to 38. Each session consists of 25-30 minutes of cardiovascular exercise,15 minutes of strengthening exercises, 5 minutes of coordination and balance exercises and 10 minutes of pelvic floor muscles training.

No Intervention: Control group

Pregnant women that are receiving usual care but are not participating in supervised physical exercise program.

Outcome Measures

Primary Outcome Measures

  1. Urinary incontinence [Gestational week 36-38]

    Urinary incontinence was measured by the International Consultation on Incontinence Questionnaire Short-Form (ICIQ-SF).

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 45 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Healthy pregnant women
Exclusion Criteria:

Contacts and Locations

Locations

Site City State Country Postal Code
1 Universidad Politécnica de Madrid Madrid Spain 28040

Sponsors and Collaborators

  • Universidad Politecnica de Madrid

Investigators

  • Study Director: Ruben Barakat Carballo, PhD, Universidad Politécnica de Madrid

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Marina Vargas Terrones, PhD, Universidad Politecnica de Madrid
ClinicalTrials.gov Identifier:
NCT03997045
Other Study ID Numbers:
  • AFIPE-001
First Posted:
Jun 25, 2019
Last Update Posted:
Jun 25, 2019
Last Verified:
Jun 1, 2019
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Marina Vargas Terrones, PhD, Universidad Politecnica de Madrid
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 25, 2019